How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

55 results for

Differin

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Differin

Differin Differin Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Differin Differin Aka: Differin , Adapalene , Epiduo From Related (...) higher price) IX. Reference Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search on the term "Differin." Click on the image (or right click) to open the source website in a new browser window. Related Studies (from Trip Database) Cost: Medications differin (on 10/19/2016 at ) DIFFERIN 0.1% CREAM Generic $3.47 per gram DIFFERIN 0.3% GEL PUMP Generic $4.46 per gram adapalene (on 5/17/2017 at ) ADAPALENE 0.1% CREAM Generic $3.47 per gram ADAPALENE 0.1

2018 FP Notebook

2. Differin

Differin Differin Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Differin Differin Aka: Differin , Adapalene , Epiduo From Related (...) higher price) IX. Reference Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search on the term "Differin." Click on the image (or right click) to open the source website in a new browser window. Related Studies (from Trip Database) Cost: Medications differin (on 10/19/2016 at ) DIFFERIN 0.1% CREAM Generic $3.47 per gram DIFFERIN 0.3% GEL PUMP Generic $4.46 per gram adapalene (on 5/17/2017 at ) ADAPALENE 0.1% CREAM Generic $3.47 per gram ADAPALENE 0.1

2015 FP Notebook

3. Clinical Efficacy of Adapalene (Differin®) 0.3% Gel in Chilean Women with Cutaneous Photoaging. (PubMed)

Clinical Efficacy of Adapalene (Differin®) 0.3% Gel in Chilean Women with Cutaneous Photoaging. Skin photoaging is a concern for many patients today, and it is important for dermatologists to evaluate new therapeutic approaches. This 6-month open-label study evaluated the effectiveness and safety of adapalene 0.3% gel in 40 Latin American women with signs of facial photoaging. Assessments at baseline, week 12, and week 24 included clinical severity grading, measurement of transepidermal water

2011 Journal of Dermatological Treatment

4. Study for Long-term Treatment of Acne Vulgaris With Skinoren Versus Differin

Study for Long-term Treatment of Acne Vulgaris With Skinoren Versus Differin Study for Long-term Treatment of Acne Vulgaris With Skinoren Versus Differin - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) . Study for Long-term Treatment of Acne Vulgaris With Skinoren Versus Differin (SKADI) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01387048 Recruitment Status : Completed First Posted : July 4, 2011 Last Update Posted : July 8, 2013 Sponsor: University of Magdeburg Collaborator: Bayer Information

2011 Clinical Trials

5. A Study to Evaluate the Efficacy and Safety of Adapalene-Clindamycin Combination Gel in the Treatment of Acne Vulgaris

Completion Date : June 2020 Estimated Study Completion Date : June 2020 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Experimental: Adapalene-Clindamycin Combination Gel Combination Product: Adapalene-Clindamycin Combination Gel 5mg Adapalene/50mg Clindamycin per 5g, applied nightly for 12 weeks Active Comparator: Adapalene Gel Drug: Adapalene Gel Differin 0.1% Gel, applied nightly for 12 weeks Other Name (...) : Differin Active Comparator: Clindamycin Gel Drug: Clindamycin Gel Clindamycin Phosphate 1% Gel applied twice daily for 12 weeks Other Name: Clindamycin Outcome Measures Go to Primary Outcome Measures : Percentage Change From Baseline in Total Lesion Counts [ Time Frame: Week 12 ] Percent change from Baseline in total lesions counts in each treatment group at Week 12. Proportion of patients who has at least a two-point reduction in Investigator Global Assessment (IGA) compared to baseline [ Time Frame

2018 Clinical Trials

6. Physiopathologic Aspects and Quality of Life in Participants With Eye Dark Circles

Chemical peel, microdermabrasion, microneedling, or dermaplaning in the previous 4 weeks Latisse, Revitalash, or other lash enhancement stimulators in the previous 1 month Retin-A®, Retin-A Micro®, Renova®, Avita®, Tazorac®, Avage® or Differin® or other similar prescription drugs within the previous 3 months Cosmetic injections (filler and/or toxins, i.e.Juvederm, Radiesse, Botox, etc.), non- ablative laser or fractional laser resurfacing in the previous 12 months Accutane® or other oral retinoid

2018 Clinical Trials

7. Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris

Collaborator: Catawba Research, LLC Information provided by (Responsible Party): Aleor Dermaceuticals Limited Study Details Study Description Go to Brief Summary: To evaluate the therapeutic equivalence and safety of Adapalene Gel 0.3% (Aleor Dermaceuticals Limited, India) and Differin® (Adapalene) Gel 0.3% (Galderma Laboratories, LP USA) in the treatment of acne vulgaris. Condition or disease Intervention/treatment Phase Acne Vulgaris Drug: Adapalene Gel 0.3% Drug: Differin 0.3% Topical Gel Drug (...) , Parallel-Group Study, Comparing Adapalene Gel 0.3% To Differin® Gel 0.3% And Both Active Treatments To A Placebo Control In The Treatment Of Acne Vulgaris Actual Study Start Date : September 17, 2018 Estimated Primary Completion Date : February 15, 2019 Estimated Study Completion Date : August 15, 2019 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Experimental: Test Product Adapalene Gel 0.3

2018 Clinical Trials

8. Relationship of Skin Related SNP to Topical Skin Care Product

Retin-A®, Retin-A Micro®, Renova®, Avita®, Tazorac®, or Differin® within 2 weeks prior to the start of the study. Use of oral retinoids within 6 months of the study start. Subjects must not have had mid-depth or superficial chemical peel or other anti-aging procedures on the face (laser, intense pulsed light, injectable fillers microdermabrasion, etc.) within 2 months of the study start. Known allergies or sensitivities to test material ingredients or any topical skin care product (i.e., alpha

2018 Clinical Trials

9. Dynamic Optical Coherence Tomography(D-OCT) Aging Study: A Preliminary Evaluation of Structural Differences Between Young and Aged Skin, Cellulite and Atrophic Acne Scars in Female Caucasian Subjects With Fitzpatrick Skin Types I-III Utilizing Non-invasiv

. These include products that address skin imperfections. This does not include a basic cleanser, moisturizer and sunscreen.(time frame 2 weeks) Chemical peel, microdermabrasion, dermaplaning, or microneedling (time frame 3 months) Retin-A®, Retin-A Micro®, Renova®, Avita®, Tazorac®, Avage® or Differin® or other similar prescription drugs (time frame 3 months) Cosmetic injections (filler and/or toxins, i.e. Juvederm, Radiesse, Botox, etc.), non-ablative laser or fractional laser resurfacing (time frame 12

2018 Clinical Trials

10. Efficacy of a Nutritional Supplement on Skin Health in Generally Healthy Adults

participating in other facial clinical trials Individuals who have routinely used alpha-hydroxy-acid (AHA) or a beta-hydroxy-acid (BHA) containing product within two weeks of baseline visit or Retin-A®, Retin-A Micro®, Renova®, Differin®, Avita®, Tazorac®, or Soriatane® within one month of baseline visit or have taken Accutane® within one year of baseline visit. Individuals who have used Retinol in the last six months prior to baseline visit Individuals with inflammatory acne lesions (i.e., papules

2018 Clinical Trials

11. Study to Assess the Cosmetic Changes in the Facial Skin After Use of a Topical Retinoid Product in Participants With Moderate to Severe Photodamage

, rosacea, skin cancer, etc.) Individuals who require electrolysis, waxing, or use depilatories on the face during the study Chemical peel or microdermabrasion within 4 weeks of study start Retin-A®, Retin-A Micro®, Renova®, Avita®,Tazorac®, Avage® or Differin® or other similar prescription drugs within 3 months of study start Cosmetic injections (filler and/or toxins, i.e. Juvederm, Radiesse, Botox, etc.), non-ablative laser or fractional laser resurfacing Accutane® or other oral retinoid, Ablative

2017 Clinical Trials

12. Split-face Study Comparing the Cosmetic Efficacy and Tolerability of Two Topical Products in Participants With Moderate Facial Melasma

(HRT) or hormones for birth control less than 3 months prior to study entry or who plan on starting, stopping, or changing doses of HRT or hormones for birth control during the study. Individuals who used any of the following medications or had any of the listed procedures within the listed time frame prior to the study start date: Retin-A®, Retin-A Micro®, Renova®, Avita®, Tazorac®, or Differin® within 3 months Had a light-depth chemical peel or microdermabrasion within 1 month Had a medium-depth

2016 Clinical Trials

14. Nutritional Supplement Efficacy on Cellular Protection and Skin Health in Generally Healthy Adults

-hydroxyl-acid (BHA) containing product within two weeks or Retin-A®, Retin-A Micro®, Renova®, Differin®, Avita®, Tazorac®, or Soriatane® within one month of the study start or have taken Accutane® within one year of the study start. Individuals who have used Retinol in the last six months Individuals with inflammatory acne lesions (i.e., papules, pustules, cysts, nodules) at the test site Individuals who have had chemical peels or dermabrasion within the last six months Individuals with known allergies

2015 Clinical Trials

15. Study Comparing Adapalene Gel 0.3% to Differin® and Both to a Placebo Control in Treatment of Acne Vulgaris

Study Comparing Adapalene Gel 0.3% to Differin® and Both to a Placebo Control in Treatment of Acne Vulgaris Study Comparing Adapalene Gel 0.3% to Differin® and Both to a Placebo Control in Treatment of Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (...) (100). Please remove one or more studies before adding more. Study Comparing Adapalene Gel 0.3% to Differin® and Both to a Placebo Control in Treatment of Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02411942 Recruitment Status : Completed First Posted : April 8, 2015 Last Update

2015 Clinical Trials

16. Adult acne: how to treat it?

nflammatory - pimples/zits N odulocystic Use Topical Treatment such as Differin gel as on CCC-F: C heek, C hin, C heek, F orehead Posted by Allergy on Labels: , , No comments: Post a Comment Subscribe to: Total Pageviews About Us All opinions expressed here are those of their authors and not of their employer. The information provided here is for educational purposes only and is not intended to provide medical advice. By accessing the web site, the visitors acknowledge that there is no physician-patient

2015 CasesBlog - Medical and Health Blog

17. An Efficiency of a Moisturizer Containing Licochalcone A, L-carnitine and 1,2-decanediol With Adapalene Gel in Acne

Primary Completion Date : February 2015 Actual Study Completion Date : July 2015 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Placebo Comparator: Adapalene gel Evening Wash face by prepared facial foam and dry your face Apply adapalene gel all over the face Other: Adapalene gel Adapalene gel: 2 fingertip unit to cover all over the face before going to bed Other Name: Adapalene gel (Differin) Placebo (...) (Differin) Active Comparator: Adapalene gel with Eucerin Morning Wash face by prepared facial foam and dry their face Apply Eucerin cream all over the face Evening Wash face by prepared facial foam and dry your face Apply adapalene gel all over the face Apply Eucerin cream all over the face Other: Adapalene gel with Eucerin Eucerin: 2 fingertip unit to cover all over the face twice a day. Adapalene gel: 2 fingertip unit to cover all over the face before going to bed Other Names: licochalcone A + L

2014 Clinical Trials

18. Nonlaser Hair Removal Techniques (Overview)

retinoids (ie, isotretinoin [Accutane], acitretin [Soriatane]) refrain from waxing until treatment has been discontinued for a minimum of 6 months to 1 year to avoid skin tearing and scarring. Patients using topical retinoids (ie, tretinoin [Retin-A, Avita], adapalene [Differin]) should also be careful when waxing to avoid injuring the skin. It is recommended that a clearly visible sign be placed in waxing salons warning clients not to wax while using systemic or topical retinoids. Waxing should

2014 eMedicine.com

19. Nonlaser Hair Removal Techniques (Treatment)

retinoids (ie, isotretinoin [Accutane], acitretin [Soriatane]) refrain from waxing until treatment has been discontinued for a minimum of 6 months to 1 year to avoid skin tearing and scarring. Patients using topical retinoids (ie, tretinoin [Retin-A, Avita], adapalene [Differin]) should also be careful when waxing to avoid injuring the skin. It is recommended that a clearly visible sign be placed in waxing salons warning clients not to wax while using systemic or topical retinoids. Waxing should

2014 eMedicine.com

20. Keratosis Pilaris (Treatment)

such as tretinoin (Retin-A), tazarotene (Tazorac), and adapalene (Differin). Specially mixed “designer” compound creams with multiple different combined ingredients can also be prescribed by physicians. Chlorine dioxide complex cleanser has been reported as effective. [ ] The affected area may be washed once or twice a day with a gentle cleanser such as Dove. Acne-prone skin may benefit from more therapeutic cleansers such as salicylic acid, or benzoyl peroxide. Lotions should be gently massaged

2014 eMedicine.com

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>